Publication | Closed Access

IMM-H004, a novel coumarin derivative compound, attenuates the production of inflammatory mediatory mediators in lipopolysaccharide-activated BV2 microglia

InflammationCytokineAnti-inflammatoryInflammatory Mediatory MediatorsMedicinePharmacologyImmunologyLipopolysaccharide-activated Bv2 MicrogliaBrain-immune InteractionImmune FunctionNeuroimmunologyNeuroinflammation